Cargando...
Ticagrelor: Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Profile: An Update
Despite advancements in treatments for acute coronary syndromes over the last 10 years, they continue to be life-threatening disorders. Currently, the standard of treatment includes dual antiplatelet therapy consisting of aspirin plus a P2Y(12) receptor antagonist. The thienopyridine class of P2Y(12...
Guardado en:
| Publicado en: | Clin Pharmacokinet |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer International Publishing
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4621714/ https://ncbi.nlm.nih.gov/pubmed/26063049 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-015-0290-2 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|